Stay updated with breaking news from Patil Developers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Torrent Pharmaceuticals consolidated net profit surged 56.45% to Rs 449 crore in Q4 FY24 as compared with Rs 287 crore recorded in Q4 FY23. Revenue from operations rose 10.2% YoY to Rs 2,745 crore in the quarter ended 31 March 2024.
Pune's real estate market thrives in Q1 2024 with increased transactions, sales values, and new project launches.
Kolte Patil share price has clocked robust gains in the last one year, doubling investors' money by jumping about 101 per cent over a year.
The small-cap stock jumped 9 per cent to hit an intraday high of Rs 569.05 after Motilal Oswal initiated its coverage with a 'Buy' rating and a target price of Rs 700
Kolte Patil Developers Q3 FY24 Results Live: Revenue decreased by 79.41% YoY & loss increased by 133.88% YoY